You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
Eurofins to acquire Villapharma in Spain
Virtual Multichannel Revenues Projected To Soar In Next Five Years
Street Talk Episode 45 - Fed Moving From Rate Hikes To Lower For Longer
Consumer Engagement Remains Challenging For OTT Players In Asia
Cord Cutting, Shaving Hits Smaller Networks Hard
Eurofins Scientific SE is acquiring Villapharma Research SL in Spain for undisclosed terms.
The transaction is expected to close in February 2017 and will help Eurofins reinforce its footprint in discovery pharmacology.
Villapharma is a provider of organic synthesis and medical chemistry services to pharmaceutical and biotech companies. The company is expected to generate more than €6 million in revenues this year.